日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacokinetic Assessment and Treatment Effect of Lusutrombopag in Child-Pugh Class C Patients: Review of Patient Data from Two Clinical Studies and Post-Marketing Surveillance

鲁苏曲波帕在Child-Pugh C级患者中的药代动力学评估和治疗效果:两项临床研究和上市后监测的患者数据回顾

Flamm, Steven L; Peck-Radosavljevic, Markus; Fukuhara, Takahiro; Bentley, Roy; Katsube, Takayuki; Ochiai, Toshimitsu; Kano, Takeshi; Tsukimura, Eri; Sasaki, Ritsue; Osaki, Yukio

Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance

鲁苏曲波帕治疗伴有血小板减少症的日本慢性肝病患者行侵入性操作的安全性和有效性:上市后监测的中期结果

Sasaki, Ritsue; Shiino, Chikako; Imawari, Michio; Bentley, Roy; Cai, Bin; Yoshida, Manami; Afdhal, Nezam